NTHL1 and familial pancreatic carcinoma: The results revealed that the embryos transplanted into pancreatic cancer PANC-1 cells treated with CP-FaP2 or CP-FaP3 showed much less tumor progression than the embryos treated with the control peptides (Fig. 9m).